UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 15
CERTIFICATE AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 0-27895*
* Client had requested to change filing type
to 0- number, but new number not assigned yet
CancerOption.com, Inc.
----------------------
(Exact name of registrant as specified in its charter)
7332 E. Butherus Drive, #101, Scottsdale, AZ 85260 480-991-8080
---------------------------------------------------------------
(Address, including zip code, and telephone number, including area code,
of registrant's principal offices)
COMMON AND PREFERRED
--------------------
(Title of each class of securities covered by this Form)
NONE
----
(Title of all other classes of securities for which a duty to file
reports under sections 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) X Rule 12h-3(b)(1)(i)
-----
Rule 12g-4(a)(1)(ii) Rule 12h-3(b)(1)(ii)
Rule 12g-4(a)(2)(i) Rule 12h-3(b)(2)(i)
Rule 12g-4(a)(2)(ii) Rule 12h-3(b)(2)(ii)
Rule 15d-6
Approximate number of holders of record as of the certification or notice date:
105
- - ---
Pursuant to the requirements of the Securities Exchange Act of 1934
CancerOption.com, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
Date: December 9, 1999 /s/ Arnold Takemoto
---------------- ------------------------
Arnold Takemoto
CEO and President
/s/ Michael Quel
------------------------
Michael Quel
CPA, CFO and Director
/s/ Douglas Brodie
------------------------
Douglas Brodie, MD
Director
1
<PAGE>
